#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Epigenetic Repression of by Latent Epstein-Barr Virus Requires the Interaction of EBNA3A and EBNA3C with CtBP


As an inhibitor of cyclin-dependent kinases, p16INK4A is an important tumour suppressor and inducer of cellular senescence that is often inactivated during the development of cancer by promoter DNA methylation. Using newly established lymphoblastoid cell lines (LCLs) expressing a conditional EBNA3C from recombinant EBV, we demonstrate that EBNA3C inactivation initiates chromatin remodelling that resets the epigenetic status of p16INK4A to permit transcriptional activation: the polycomb-associated repressive H3K27me3 histone modification is substantially reduced, while the activation-related mark H3K4me3 is modestly increased. Activation of EBNA3C reverses the distribution of these epigenetic marks, represses p16INK4A transcription and allows proliferation. LCLs lacking EBNA3A express relatively high levels of p16INK4A and have a similar pattern of histone modifications on p16INK4A as produced by the inactivation of EBNA3C. Since binding to the co-repressor of transcription CtBP has been linked to the oncogenic activity of EBNA3A and EBNA3C, we established LCLs with recombinant viruses encoding EBNA3A- and/or EBNA3C-mutants that no longer bind CtBP. These novel LCLs have revealed that the chromatin remodelling and epigenetic repression of p16INK4A requires the interaction of both EBNA3A and EBNA3C with CtBP. The repression of p16INK4A by latent EBV will not only overcome senescence in infected B cells, but may also pave the way for p16INK4A DNA methylation during B cell lymphomagenesis.


Vyšlo v časopise: Epigenetic Repression of by Latent Epstein-Barr Virus Requires the Interaction of EBNA3A and EBNA3C with CtBP. PLoS Pathog 6(6): e32767. doi:10.1371/journal.ppat.1000951
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1000951

Souhrn

As an inhibitor of cyclin-dependent kinases, p16INK4A is an important tumour suppressor and inducer of cellular senescence that is often inactivated during the development of cancer by promoter DNA methylation. Using newly established lymphoblastoid cell lines (LCLs) expressing a conditional EBNA3C from recombinant EBV, we demonstrate that EBNA3C inactivation initiates chromatin remodelling that resets the epigenetic status of p16INK4A to permit transcriptional activation: the polycomb-associated repressive H3K27me3 histone modification is substantially reduced, while the activation-related mark H3K4me3 is modestly increased. Activation of EBNA3C reverses the distribution of these epigenetic marks, represses p16INK4A transcription and allows proliferation. LCLs lacking EBNA3A express relatively high levels of p16INK4A and have a similar pattern of histone modifications on p16INK4A as produced by the inactivation of EBNA3C. Since binding to the co-repressor of transcription CtBP has been linked to the oncogenic activity of EBNA3A and EBNA3C, we established LCLs with recombinant viruses encoding EBNA3A- and/or EBNA3C-mutants that no longer bind CtBP. These novel LCLs have revealed that the chromatin remodelling and epigenetic repression of p16INK4A requires the interaction of both EBNA3A and EBNA3C with CtBP. The repression of p16INK4A by latent EBV will not only overcome senescence in infected B cells, but may also pave the way for p16INK4A DNA methylation during B cell lymphomagenesis.


Zdroje

1. BornkammGW

HammerschmidtW

2001 Molecular virology of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356 437 459

2. Thorley-LawsonDA

GrossA

2004 Persistence of the Epstein-Barr Virus and the Origins of Associated Lymphomas. The New England journal of medicine 350 1328 1337

3. RoughanJE

Thorley-LawsonDA

2009 The intersection of Epstein-Barr virus with the germinal center. J Virol 83 3968 3976

4. CrawfordDH

2001 Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356 461 473

5. TouitouR

O'NionsJ

HeaneyJ

AlldayMJ

2005 Epstein-Barr virus EBNA3 proteins bind to the C8/alpha7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells. J Gen Virol 86 1269 1277

6. TomkinsonB

RobertsonE

KieffE

1993 Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 67 2014 2025

7. TomkinsonB

KieffE

1992 Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro. J Virol 66 2893 2903

8. HertleML

PoppC

PetermannS

MaierS

KremmerE

2009 Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes. PLoS Pathogens 5 e1000506

9. Le RouxA

KerdilesB

WallsD

DedieuJF

PerricaudetM

1994 The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology 205 596 602

10. WaltzerL

PerricaudetM

SergeantA

ManetE

1996 Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA. J Virol 70 5909 5915

11. RadkovSA

TouitouR

BrehmA

RoweM

WestM

1999 Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. J Virol 73 5688 5697

12. CludtsI

FarrellPJ

1998 Multiple functions within the Epstein-Barr virus EBNA-3A protein. J Virol 72 1862 1869

13. BainM

WatsonRJ

FarrellPJ

AlldayMJ

1996 Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA. J Virol 70 2481 2489

14. BourillotPY

WaltzerL

SergeantA

ManetE

1998 Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa. J Gen Virol 79 (Pt2) 363 370

15. KnightJS

LanK

SubramanianC

RobertsonES

2003 Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines. J Virol 77 4261 4272

16. TouitouR

HickabottomM

ParkerG

CrookT

AlldayMJ

2001 Physical and Functional Interactions between the Corepressor CtBP and the Epstein-Barr Virus Nuclear Antigen EBNA3C. J Virol 75 7749 7755

17. HickabottomM

ParkerGA

FreemontP

CrookT

AlldayMJ

2002 Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP). J Biol Chem 277 47197 47204

18. ChinnaduraiG

2007 Transcriptional regulation by C-terminal binding proteins. Int J Biochem Cell Biol 39 1593 1607

19. ShiY

SawadaJ

SuiG

Affar elB

WhetstineJR

2003 Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422 735 738

20. ShiY

LanF

MatsonC

MulliganP

WhetstineJR

2004 Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119 941 953

21. DahiyaA

WongS

GonzaloS

GavinM

DeanDC

2001 Linking the Rb and polycomb pathways. Mol Cell 8 557 569

22. MrozEA

BairdAH

MichaudWA

RoccoJW

2008 COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells. Cancer Res 68 6049 6053

23. GilJ

PetersG

2006 Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat Rev Mol Cell Biol 7 667 677

24. ParkerGA

CrookT

BainM

SaraEA

FarrellPJ

1996 Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene 13 2541 2549

25. SerranoM

LinAW

McCurrachME

BeachD

LoweSW

1997 Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 593 602

26. ParkerGA

TouitouR

AlldayMJ

2000 Epstein-Barr virus EBNA3C can disrupt multiple cell cycle checkpoints and induce nuclear division divorced from cytokinesis. Oncogene 19 700 709

27. ChoudhuriT

VermaSC

LanK

MurakamiM

RobertsonES

2007 The ATM/ATR signaling effector Chk2 is targeted by Epstein-Barr virus nuclear antigen 3C to release the G2/M cell cycle block. J Virol 81 6718 6730

28. GruhneB

SompallaeR

MasucciMG

2009 Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints. Oncogene 28 3997 4008

29. KnightJS

RobertsonES

2004 Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity. J Virol 78 1981 1991

30. KnightJS

SharmaN

RobertsonES

2005 Epstein–Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proc Natl Acad Sci U S A 102 18562 18566

31. KnightJS

SharmaN

RobertsonES

2005 SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen. Mol Cell Biol 25 1749 1763

32. BajajBG

MurakamiM

CaiQ

VermaSC

LanK

2008 Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoprotein. J Virol 82 4082 4090

33. SahaA

MurakamiM

KumarP

BajajB

SimsK

2009 Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2. J Virol 83 4652 4669

34. YiF

SahaA

MurakamiM

KumarP

KnightJS

2009 Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. Virology 388 236 247

35. MaruoS

WuY

IshikawaS

KandaT

IwakiriD

2006 Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells. Proc Natl Acad Sci U S A 103 19500 19505

36. MaruoS

JohannsenE

IllanesD

CooperA

KieffE

2003 Epstein-Barr Virus nuclear protein EBNA3A is critical for maintaining lymphoblastoid cell line growth. J Virol 77 10437 10447

37. AndertonE

YeeJ

SmithP

CrookT

WhiteRE

2008 Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. Oncogene 27 421 433

38. PaschosK

SmithP

AndertonE

MiddeldorpJM

WhiteRE

2009 Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathogens 5 e1000492

39. SimonJA

KingstonRE

2009 Mechanisms of Polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 10 697

40. BrackenAP

HelinK

2009 Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer 9 773 784

41. DelecluseHJ

HilsendegenT

PichD

ZeidlerR

HammerschmidtW

1998 Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95 8245 8250

42. WhiteRE

CalderwoodMA

WhitehouseA

2003 Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence. J Gen Virol 84 3393 3403

43. NeuhierlB

FeederleR

HammerschmidtW

DelecluseHJ

2002 Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection. Proc Natl Acad Sci U S A 99 15036 15041

44. KiaSK

GorskiMM

GiannakopoulosS

VerrijzerCP

2008 SWI/SNF Mediates Polycomb Eviction and Epigenetic Reprogramming of the INK4b-ARF-INK4a Locus. Mol Cell Biol 28 3457 3464

45. BarradasM

AndertonE

AcostaJC

LiS

BanitoA

2009 Histone demethylase JMJD3 contributes to epigenetic control of INK4a/ARF by oncogenic RAS. Genes Dev 23 1177 1182

46. AggerK

CloosPA

RudkjaerL

WilliamsK

AndersenG

2009 The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev 23 1171 1176

47. BernsteinBE

MikkelsenTS

XieX

KamalM

HuebertDJ

2006 A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125 315 326

48. LukasJ

ParryD

AagaardL

MannDJ

BartkovaJ

1995 Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375 503 506

49. SewaltRG

GunsterMJ

van der VlagJ

SatijnDPE

OtteAP

1999 C-Terminal Binding Protein Is a Transcriptional Repressor That Interacts with a Specific Class of Vertebrate Polycomb Proteins. Mol Cell Biol 19 777 787

50. AtchisonL

GhiasA

WilkinsonF

BoniniN

AtchisonML

2003 Transcription factor YY1 functions as a PcG protein in vivo. EMBO Journal 22 1347 1358

51. SrinivasanL

AtchisonML

2004 YY1 DNA binding and PcG recruitment requires CtBP. Genes Dev 18 2596 2601

52. LiH

ColladoM

VillasanteA

StratiK

OrtegaS

2009 The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460 1136 1139

53. KrivtsovAV

ArmstrongSA

2007 MLL translocations, histone modifications and leukaemia stem-cell development. Nature Rev Cancer 7 823 833

54. TiwariVK

McGarveyKM

LicchesiJD

OhmJE

HermanJG

2008 PcG proteins, DNA methylation, and gene repression by chromatin looping. PLoS Biology 6 2911 2927

55. MujtabaS

ManzurKL

GurnonJR

KangM

Van EttenJL

2008 Epigenetic transcriptional repression of cellular genes by a viral SET protein. Nat Cell Biol 10 1114 1122

56. YangX

HeZ

XinB

CaoL

2000 LMP1 of Epstein-Barr virus suppresses cellular senescence associated with the inhibition of p16INK4a expression. Oncogene 19 2002 2013

57. OhtaniN

BrennanP

GaubatzS

SanijE

HertzogP

2003 Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5. J Cell Biol 162 173 183

58. KeshetI

SchlesingerY

FarkashS

RandE

HechtM

2006 Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat Genet 38 149 153

59. SchlesingerY

StraussmanR

KeshetI

FarkashS

HechtM

2007 Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39 232 236

60. VireE

BrennerC

DeplusR

BlanchonL

FragaM

2006 The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439 871 874

61. OhmJE

McGarveyKM

YuX

ChengL

SchuebelKE

2007 A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39 237 242

62. WidschwendterM

FieglH

EgleD

Mueller-HolznerE

SpizzoG

2007 Epigenetic stem cell signature in cancer. Nat Genet 39 157 158

63. CedarH

BergmanY

2009 Linking DNA methylation and histone modification: patterns and paradigms. Nature Rev Genet 10 295 304

64. KlangbyU

OkanI

MagnussonKP

WendlandM

LindP

1998 p16/INK4a and p15/INK4b gene methylation and absence of p16/INK4a mRNA and protein expression in Burkitt's lymphoma. Blood 91 1680 1687

65. LindstromMS

WimanKG

2002 Role of genetic and epigenetic changes in Burkitt lymphoma. Semin Cancer Biol 12 381 387

66. Hernandez-MunozI

TaghaviP

KuijlC

NeefjesJ

van LohuizenM

2005 Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1. Mol Cell Biol 25 11047 11058

67. SchaeperU

BoydJM

VermaS

UhlmannE

SubramanianT

1995 Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci U S A 92 10467 10471

68. BrownAC

BaigentSJ

SmithLP

ChattooJP

PetherbridgeLJ

2006 Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus. Proc Natl Acad Sci U S A 103 1687 1692

69. LeeS

SakakibaraS

MaruoS

ZhaoB

CalderwoodMA

2009 Epstein-Barr virus nuclear protein 3C domains necessary for lymphoblastoid cell growth: interaction with RBP-Jkappa regulates TCL1. J Virol 83 12368 12377

70. MaruoS

WuY

ItoT

KandaT

KieffED

2009 Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth. Proc Natl Acad Sci U S A 106 4419 4424

71. HowleyPM

LivingstonDM

2009 Small DNA tumor viruses: large contributors to biomedical sciences. Virology 384 256 259

Štítky
Hygiena a epidemiológia Infekčné lekárstvo Laboratórium

Článok vyšiel v časopise

PLOS Pathogens


2010 Číslo 6
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#